Recognizing immunoglobulin G4-related overlap syndromes in patients with pancreatic and hepatobiliary diseases

Canadian Journal of Gastroenterology

Volumn 22, Issue 10, 2008, Pages 840-846

  Montano Loza, Aldo J ^a   Lalor, Eoin ^a   Mason, Andrew L ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Autoimmune pancreatitis; Immunoglobulin G4 hepatopathy; Immunoglobulin G4 related systemic disease; Immunoglobulin G4 associated cholangitis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN G4; PREDNISOLONE; PREDNISONE; IMMUNOGLOBULIN G;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE PANCREATITIS; BILIARY TRACT SURGERY; CHOLANGITIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; HEPATOBILIARY DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PANCREAS DISEASE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVIEW; BLOOD; FEMALE; IMMUNOLOGY; MALE; PANCREATITIS; PATHOLOGY; SCLEROSING CHOLANGITIS; SYNDROME;

AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; MALE; PANCREATITIS; SYNDROME;

EID: 58249094317     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/586173     Document Type: Review

References (66)

1. Gish RG, Mason A. Autoimmune liver disease. Current standards, future directions. Clin Liver Dis 2001;5:287-314.
2. Abdalian R, Dhar P, Jhaveri K, Haider M, Guindi M, Heathcote EJ. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging. Hepatology 2008;47:949-57.
3. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology 1998;28:296-301.
4. Poupon R, Chazouilleres O, Corpechot C, Chretien Y. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology 2006;44:85-90.
5. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
6. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas 2004;29:167-8.
7. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-4.
8. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: A systemic immune complex mediated disease. Am J Surg Pathol 2006;30:1537-45.
9. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007;20:23-8.
10. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: The Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-6.
11. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008;14:3948-55.
12. Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis: A differential diagnosis for classical autoimmune hepatitis. Gut 2007;56:1471-2.
13. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: Association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007;46:463-71.
14. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: A study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-563.
15. Takahashi N, Kawashima A, Fletcher JG, et al. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007;242:791-801.
16. Cheuk W, Yuen HK, Chu SY, Chiu EK, Lam LK, Chan JK. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 2008;32:671-81.
17. Björnsson E, Chari ST, Smyrk TC, et al. IgG4 associated cholangitis: Description of an emerging clinical entity based on review of the literature. Hepatology 2007;45:1547-54.
18. Takato H, Yasui M, Ichikawa Y et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 2008;47:291-4.
19. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: Do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004;28:1193-203.
20. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-8.
21. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006;355:2670-6.
22. Lara LP, Chari ST. Autoimmune pancreatitis. Curr Gastroenterol Rep 2005;7:101-6.
23. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003;98:2811-2.
24. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005;30:76-82.
25. Kojima E, Kimura K, Noda Y, et al. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003;38:603-7.
26. Angulo P, Batts KP, Jorgensen RA, LaRusso NA, Lindor KD. Oral budesonide in the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000;95:2333-7.
27. Chen W, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2004;3:CD004036.
28. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: Autoimmune pancreatitis: Does it exist? Pancreas 2003;27:1-13.
29. Weber SM, Cubukcu-Dimopulo O, Palesty JA, et al. Lymphoplasmacytic sclerosing pancreatitis: Inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003;7:129-37.
30. Kloppel G, Luttges J, Lohr M, et al. Autoimmune pancreatitis: Pathological, clinical, and immunological features. Pancreas 2003;27:14-9.
31. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: Are they all 'chronic pancreatitis'? Am J Surg Pathol 2003;27:110-20.
32. Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003;52:683-7.
33. Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol 2004;28:1114.
34. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: Introducing the Mayo Clinic's HISORt criteria. J Gastroenterol. 2007;42:39-41
35. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4.
36. Kino-Ohsaki J, Nishimori I, Morita M, et al. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Gastroenterology 1996;10:1579-86.
37. Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007;4:314-23.
38. Chari ST, Murray JA. Autoimmune pancreatitis, Part II: The relapse. Gastroenterology 2008;134:625-8.
39. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: Results from a long-term follow-up study. Pancreatology 2005;5:234-8.
40. Kamisawa T, Okamoto A, Wakabayashi T, Watanabe H, Sawabu N. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol 2008;43:609-13.
41. Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol 2007;42:59-62.
42. Bartholomew LG, Cain JC, Woolner LB, Utz DC, Ferris DO. Sclerosing cholangitis: Its possible association with Riedel's struma and fibrous retroperitonitis. Report of two cases. N Engl J Med 1963;269:8-12.
43. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: Clinical profile and response to therapy. Gastroenterolgoy 2008;134:706-15.
44. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387-95.
45. Stathopoulos G, Nourmand AD, Blackstone M, Andersen D, Baker AL. Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumor. J Clin Gastroenterol 1995;21:143-148.
46. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997;41:263-8.
47. Nieminen U, Koivisto T, Kahri A, Farkkila M. Sjogren's syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations. Am J Gastroenterol 1997;92:139-42.
48. Erdogan D, Kloek JJ, Ten Kate FJ, et al. Immunoglobulin G(4)-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg 2008;95:727-34.
49. Laitt RD, Hubscher SG, Buckels JA, Darby S, Elias E. Sclerosing cholangitis associated with multifocal fibrosis: A case report. Gut 1992;33:1430-32.
50. Chutaputti A, Burrell MI, Boyer JL. Pseudotumor of the pancreas associated with retroperitoneal fibrosis: A dramatic response to corticosteroid therapy. Am J Gastroenterol 1995;90:1155-8.
51. Kazumori H, Ashizawa N, Moriyama N, et al. Primary sclerosing pancreatitis and cholangitis. Int J Pancreatol 1998;24:123-7.
52. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999;354:43-4.
53. Horiuchi A, Kawa S, Hamano H, Ochi Y, Kiyosawa K. Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: Report of 2 case reports and review. Gastrointest Endosc 2001;53:518-22.
54. Fernandez-del Castillo CF, Sahani DV, Lauwers GY. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med 2003;349:893-901.
55. Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003;38:603-7.
56. Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'. Pathol Int 2005;55:405-11.
57. Fukui T, Okazaki K, Yoshizawa H, et al. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren's syndome. Pancreatology 2005;5:86-91.
58. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008;6:364-6.
59. Park DH, Kim M-H, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQβ1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008;134:440-6.
60. Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007;42:550-9.
61. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005;30:20-5.
62. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999;30:325-32.
63. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004;99:523-26.
64. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
65. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76.
66. Kamisawa T, Egawa N, Tsuruta K et al. Primary sclerosing cholangitis may be overestimated in Japan. J Gastroenterol 2005;40;318-9